Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease

by Tumas,Vitor, Borges,Vanderci, Ballalai-Ferraz,Henrique, Zabetian,Cyrus P., Mata,Ignácio F., Brito,Manuelina M.C., Foss,Maria Paula, Novaretti,Nathalia, Santos-Lobato,Bruno Lopes
Published 2016

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease

by SANTOS-LOBATO,Bruno Lopes, SCHUMACHER-SCHUH,Artur F., RIEDER,Carlos R. M., HUTZ,Mara H., BORGES,Vanderci, FERRAZ,Henrique Ballalai, MATA,Ignacio F., ZABETIAN,Cyrus P., TUMAS,Vitor
Published 2020

Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cog...

by Sobreira,Emmanuelle, Pena-Pereira,Márcio A., Eckeli,Alan L., Sobreira-Neto,Manoel A., Chagas,Marcos H. N., Foss,Maria P., Cholerton,Brenna, Zabetian,Cyrus P., Mata,Ignacio F., Tumas,Vitor
Published 2015

Genetics of Parkinson’s disease in Brazil: a systematic review of monogenic forms

by Santos-Lobato,Bruno L., Schumacher-Schuh,Artur, Mata,Ignacio F., Letro,Grace H., Braga-Neto,Pedro, Brandão,Pedro R. P., Godeiro-Junior,Clécio O., Coletta,Marcus V. Della, Camargos,Sarah T., Borges,Vanderci, Rieder,Carlos R. M., Tumas,Vitor
Published 2021